Antonia Coppin-Renz, MD
Otsuka Pharmaceutical Development & Commercialisation Europe GmbH, Hessen, Germany
Original Research
Effects of a Digital Medicine System on Psychiatric Hospitalization Rates for Adults With Schizophrenia
April 11, 2022
This clinical trial investigated whether hospitalization rates improved when patients with schizophrenia were treated via a digital medicine system (aripiprazole tablets with sensor) versus oral standard-of-care therapy.